Melanoma - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Extending Immunotherapy for Metastatic Melanoma
(Posted: 08/08/2006, Updated: 12/26/2007) - This study will assess the safety and antitumor activity of lymphocytes that have been genetically engineered to recognize the MART-1 antigen in patients with metastatic melanoma.
- Regional Chemotherapy for Inoperable Liver Metastases
(Posted: 10/09/2007) - In this trial, doctors are testing a method of delivering chemotherapy regionally to the liver called percutaneous isolated hepatic arterial perfusion (PHP) in patients with liver metastases from ocular (eye) or cutaneous (skin) melanoma.
- Immunotherapy for Patients with Metastatic Melanoma
(Posted: 10/12/2004, Updated: 07/18/2007) - With this trial, researchers are testing the safety and tumor-fighting ability of a new type of immunotherapy agent in patients with metastatic melanoma that has not responded to standard treatment.
- Biological Therapy for Advanced Kidney Cancer or Melanoma
(Posted: 07/10/2007) - This phase I clinical trial will assess the safety and tolerability of a new biological agent called GC1008 in patients with advanced kidney cancer or melanoma.
- Gene Therapy for Metastatic Cancer
(Posted: 11/21/2006) - In the trial, researchers will harvest normal T lymphocytes from patients' blood and modify these immune system cells to recognize p53 protein, a common hallmark of many cancers. The modified cells will be enriched in the laboratory and then infused back into the patients.